• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Noel G. Boyle Discusses Benefits of Dabigatran Versus Warfarin for Treatment of Atrial Fibrillation

Article

Dr. Noel G. Boyle, Professor of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, talks about new medications that can work as alternatives to warfarin for atrial fibrillation patients who are at risk for stroke.

In addition, Dr. Boyle discusses the benefits of dabigatran (Brand name: Pradaxa) versus warfarin for the treatment of patients with atrial fibrillation. According to Dr. Boyle, advantages of dabigatran include no patient monitoring, fixed dosing, and less drug interactions. Disadvantages of dabigatran include twice daily dosing and no easy method for monitoring, according to Dr. Boyle.

Related Videos
Dr Steven Manobianco
Dr David Kuter
Roy Mathew, MD, screenshot
Dr Marco del Riccio
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Dr David Kuter
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Related Content
Our key takeaways from SABCS 2025 range from camizestrant and T-DXd data to menopause care and alcohol-related breast cancer risk.

ICYMI: Highlights From SABCS 2025

December 29th 2025
Article

New therapies and individualized care plans for menopausal women highlighted the most-read 2025 SABCS coverage.

Read More

managed care cast logo

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025
Podcast

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

The top 5 video interviews of 2025 | Image Credit: Venngage

Top 5 Most-Watched Video Interviews of 2025

December 25th 2025
Article

This year's most-watched video evaluated how President Donald Trump's rescission of several Biden-era executive orders may impact Medicaid and Medicare initiatives.

Read More

AJMC Managed Care Cast

AJMC® Editors Reflect on Milestone Year and Look to 2026

December 16th 2025
Podcast

The editors in chief of AJMC discuss the key managed care research and news from 2025 as the journal celebrated its 30th anniversary.

Listen

How expiring ACA subsidies could reshape coverage choices for employees and employers. | Image credit: @iQoncept-stock.adobe.com.jpeg

What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light

December 2nd 2025
Article

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape employer health coverage strategy.

Read More

AJMC Q&A with Svetlana Barbarash | Background image credit: ipopba – stock.adobe.com

Provider Shortages in Nevada Leave Gaps in Cardiovascular Care: Svetlana Barbarash, MD

November 25th 2025
Article

Svetlana Barbarash, MD, outlines the lack of cardiologists and transplant services in Las Vegas and the policy changes needed to close gender gaps in care.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.